Eric Hoffman
Professor
United States of America
Dr. Hoffman is a human molecular geneticist with expertise in clinical trials and drug development in Duchenne muscular dystrophy and other neuromuscular disorders. He is Professor and Associate Dean at Binghamton University – State University of New York in the School of Pharmacy and Pharmaceutical Sciences. He has co-founded ReveraGen, TRiNDS, and AGADA Biosciences.
Disclosure statement
Eric holds the following positions:
ReveraGen BioPharma. Co-founder, share holder, VP Research.
TRiNDS LLC. Co-founder, share holder, Board member.
AGADA Biosciences. Co-founder, share holder, CEO.
Organisations
CINRG
The Cooperative International Neuromuscular Research Group was founded in 1999 as the Clinical Research Arm of the Duchenne Muscular Dystrophy Researc …
Committees
TACT Extended Committee
Introduction to TACT Annamaria De Luca, as TACT chair, is leading this exciting initiative with the support of the TACT core, nominated committee memb …
TREAT-NMD Task-Force
An academic task force consisting of key clinical and scientific experts from around the world has been established to help develop the future focus a …
